Catholic CEO, Catholic Business Journal Columnist, and A Host of The Mentors Radio: BryoLogyx Announces Cooperative Research and Development Agreement for Bryostatin-1 With National Cancer Institute

Catholic CEO, Catholic Business Journal Columnist, and A Host of The Mentors Radio: BryoLogyx Announces Cooperative Research and Development Agreement for Bryostatin-1 With National Cancer Institute

We at Catholic Business Journal are so proud of long-time Catholic Business Journal columnist Thomas M. Loarie, CEO of BryoLogyx, Inc.,  and one of the three Catholic hosts of The Mentors Radio program which airs weekly in the San Francisco Greater Bay Area and in the greater Dallas-Fort Worth region, for the breakthrough cancer immunology-related…

Co-host of The Mentors Radio Show Tom Loarie leads Bryologyx in Radically improving cancer immunotherapies, announcing new VP David Crockford

Co-host of The Mentors Radio Show Tom Loarie leads Bryologyx in Radically improving cancer immunotherapies, announcing new VP David Crockford

BryoLogyx Inc., (www.BryoLogyx.com), a privately-held, pre-clinical company developing a new class of proprietary drugs to enhance the response rates and treatment durability of cancer immunotherapies, announced today that David Crockford has joined the Company as vice president of clinical development and logistics, a new position. Crockford joins BryoLogyx after more than 40 years at pharmaceutical…